title: [Pancreatic carcinoma: conservative and adjuvant therapy].
abstract: Patient with pancreatic have a median age of 78 years and without treatment an average survival of only a few months. Tumor stage and patient will determine the therapy. Patients with metastases or a high surgical risk are treated symptomatically. Jaundice, nausea, pain, and anorexia are the most relevant symptoms. The main symptom requiring treatment are jaundice and pruritus due to extrahepatic biliary obstruction which can be relieved in most cases by endoscopic placement of a biliary endoprosthesis. Pancreatic cancer may be a highly painful disease. Therapeutic modalities include, in addition to antitumoral treatment, narcotic and nonnarcotic analgesics, neurolytic celiac blockage, psychological support, and the treatment of associated symptoms such as emesis and constipation. Although radio- or chemotherapy show positive responses in a subgroup of patients, average survival remains unchanged with monotherapy. In contrast, improved median survival following combined radio-and chemotherapy has been demonstrated both in patients with locally unresectable pancreatic cancer and in patients after curative tumor resection.
authors.affiliation: Abteilung für Gastroenterologie, Inselspital, Bern.
authors.forename: A
authors.initials: A
authors.lastname: Schmassmann
mesh_terms: D000368:Aged; D000698:Analgesia / Q000379:methods; D003131:Combined Modality Therapy; D004032:Diet; D006801:Humans; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D015996:Survival Rate
vernacular_title: Pankreaskarzinom: Konservative und adjuvante Therapie.